The Allo Podcast brings you into the complex world of maternal red blood cell alloimmunization and Hemolytic Disease of the Fetus and Newborn (HDFN.) We share real life patient experiences, valuable insights for providers and care teams, and easy to understand monitoring and treatment information. We empower you to advocate for the best possible care, and we have a great time doing it.

The Allo Podcast
Claim This Podcastby Allo Hope Foundation
Podcast Authority
Beta
Podcast Overview
The Allo Podcast brings you into the complex world of maternal red blood cell alloimmunization and Hemolytic Disease of the Fetus and Newborn (HDFN.) We share real life patient experiences, valuable insights for providers and care teams, and easy to understand monitoring and treatment information. We empower you to advocate for the best possible care, and we have a great time doing it.
Language
🇺🇲
Publishing Since
8/29/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for The Allo Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

April 14, 2026
Unseen Battles, Unmatched Strength: HDFN in Kenya
<p>Rose and Katie return for an intimate discussion with Bethany and Molly about the realities of HDFN in Kenya. The group discuss the five pillars of prevention, diagnosis, monitoring, treatment and maternal support and what they each look like for Kenyan families. An important and humbling episode for listeners who may not have access to a deeper understanding of HDFN realities in underserved communities.</p><p>Watch this episode on <a href="https://youtu.be/cvqjF44pKyQ">YouTube</a></p><p>View all of our resources at <a href="http://www.allohopefoundation.org">www.allohopefoundation.org</a></p><p>If you are an alloimmunized mother from any country, you are welcome in our Facebook support group called “Antibodies in Pregnancy: An AHF Support Group. Join here. <a href="https://www.facebook.com/groups/antibodiesinpregnancy">https://www.facebook.com/groups/antibodiesinpregnancy</a></p><p>Please consider donating to AHF. If you are a listener, you know we do a lot with a little. Not sure how much will make a difference? An antibody screen in Kenya costs $13 USD. A dose of RhIG for a mother who cannot afford it is $80 USD. </p><p><a href="https://allohopefoundation.org/get-involved/donate/">Click here </a> to make a one-time or recurring donation.</p>

April 7, 2026
Baby is Home, What Now?
<p>Molly and Bethany address the common question many families wonder about what to do to monitor their HDFN baby once they’re home, and how to know when baby is finally cleared of HDFN. They share their children’s post-discharge monitoring plans, which cover a full spectrum of HDFN severity.</p><p>If you haven’t already, listen to Season 1 Episode 13 about the neonatal HDFN period. Common terms discussed in this episode: </p><ul><li>Newborn hemolytic anemia</li><li>Newborn hyperbilirubinemia </li><li>Hemoglobin/hematocrit</li><li>Reticulocytes</li><li>Erythropoietin/darbepoetin/ESAs</li><li>Thrombocytopenia</li><li>Neutropenia</li><li>Pediatric hematologist</li></ul><p>Example transfusion thresholds provided in our Excellent Neonatal Care Practices resource <a href="https://allohopefoundation.org/advocate/provider-checklist/">here.</a></p><p>References in this episode: </p><p>Clinical study showing the effectiveness of ESAs for neonatal HDFN: </p><p>Ree IM, de Haas M, van Geloven N, Juul SE, de Winter D, Verweij EJ, Oepkes D, van der Bom JG, Lopriore E. Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial. The Lancet Haematology. 2023 Dec 1;10(12):e976-84.</p><p>Watch this episode on <a href="https://youtu.be/wvOoTaybcW0">YouTube</a></p><p>View all of our resources at <a href="http://www.allohopefoundation.org">www.allohopefoundation.org</a></p><p>If you are an alloimmunized mother from any country, you are welcome in our Facebook support group called “Antibodies in Pregnancy: An AHF Support Group. Join here. <a href="https://www.facebook.com/groups/antibodiesinpregnancy">https://www.facebook.com/groups/antibodiesinpregnancy</a></p><p>Please consider donating to AHF. If you are a listener, you know we do a lot with a little. Not sure how much will make a difference? An antibody screen in Kenya costs $13 USD. A dose of RhIG for a mother who cannot afford it is $80 USD. </p><p><a href="https://allohopefoundation.org/get-involved/donate/">Click here</a></p><p> to make a one-time or recurring donation.</p>

March 31, 2026
Quick and Nerdy: Iron
<p>Bethany and Molly address iron and its dangers to the HDFN newborn in this quick, science-based episode. Together they address the dangers of iron overload and the confusion around why iron is often mistakenly included in the treatment regimen for newborns experiencing alloimmunized anemia, as well as treatments for extreme conditions. </p><p>Watch this episode on <a href="https://youtu.be/y7ZznU6Sw5M">YouTube</a></p><p>View all of our resources at <a href="http://www.allohopefoundation.org">www.allohopefoundation.org</a></p><p>If you are an alloimmunized mother from any country, you are welcome in our Facebook support group called “Antibodies in Pregnancy: An AHF Support Group. Join here. <a href="https://www.facebook.com/groups/antibodiesinpregnancy">https://www.facebook.com/groups/antibodiesinpregnancy</a></p><p>Please consider donating to AHF. If you are a listener, you know we do a lot with a little. Not sure how much will make a difference? An antibody screen in Kenya costs $13 USD. A dose of RhIG for a mother who cannot afford it is $80 USD. <a href="https://allohopefoundation.org/get-involved/donate/">Click here</a> to make a one-time or recurring donation.</p><p>References in this episode: </p><p>Study on iron overload at birth in HDFN newborns: Rath ME, Smits-Wintjens VE, Oepkes D, Walther FJ, Lopriore E. Iron status in infants with alloimmune haemolytic disease in the first three months of life. Vox Sang. 2013 Nov;105(4):328-33. doi: 10.1111/vox.12061. Epub 2013 Jun 27. <a href="https://scholarlypublications.universiteitleiden.nl/access/item%3A2881417/download#page=194">Available here.</a></p><p>Case report of iron overload resolving: Adam DL, Bowes L, Goodyear L, Moorehead PC. Conservative Management of Hyperferritinemia in Hemolytic Disease of the Fetus and Newborn: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2021 Mar 1;43(2):73-76. </p><p><a href="https://www.academia.edu/download/112861145/mph.000000000000158620240329-1-xfsqjs.pdf">Available here</a></p><p>.</p>
54 total episodes available
Recent guests on The Allo Podcast
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr Timothy Bahr
Guest
Dr Kara Markham
Guest
Amanda
Guest
Dr Ken Moise
Guest
Rose
Guest
Rose Murage
Guest
Agne
Guest
Emily Rusch
Guest
Deep-dive analytics for The Allo Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is The Allo Podcast?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.